A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders
NCT02246218
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Urea Cycle Disorder
Interventions
DRUG:
RAVICTI
Sponsor
Amgen